Skip to main content
  • Image
    Intica 5 HF-T QP
  • Image
    Intica 5 HF-T

Intica 5 HF-T QP/HF-T

360° CRT

BIOTRONIK CRT-D systems offer all the options needed for implantation and therapy optimization. Plus superior solutions to provide a truly unique patient care.For optimal support along the CRT healthcare journey, the Intica 5 CRT-D series offers LV VectorOpt, BIOTRONIK Home Monitoring®, MRI AutoDetect and DX technology.



Product Highlights

LV VectorOpt

LV VectorOpt

LV VectorOpt including RV-LV conduction time simplifies the process to select the right LV pacing vector

Icon CardioMessenger Smart

BIOTRONIK Home Monitoring®

BIOTRONIK Home Monitoring offers outstanding clinical results by being able to reduce mortality in CRT-D patients by more than 50%

Icon DX

DX Technology

The world’s only atrial sensing technology that provides atrial diagnostics without an atrial lead — now offers its benefits to CRT patients

Product Details

  • Intelligent technology MRI AutoDetect simplifies MRI access by automatically detecting an MR environment and switching the system to safe MRI mode, for a period of 14 days max.
  • ShockReduct covers all aspects of ICD therapy with accurate sensing, effective therapy and continuous patient monitoring to significantly reduce unnecessary shocks


Increasing CRT Response
Simplify your process to select the right pacing vector with LV VectorOpt and fight non-response with only limited impact on battery with MultiPole Pacing (MPP)

Avoiding Inappropriate Shocks
More protection, more peace of mind for your patients with ShockReduct, using the latest tachycardia detection, therapy and monitoring tools

Increased Lifetime
Offer your patients the only remote monitoring system that has demonstrated a more than 50% mortality reduction for CRT-D patients, as proven by the IN-TIME trial1

Simplifying MRI Access
Ensure optimal patient therapy and simplified workflows with intelligent MRI AutoDetect sensor technology

Improving AF Management
DX technology in CRT offers atrial information and full range of VT/SVT discrimination for selected patient groups not receiving an atrial lead

Contact Us

I prefer to be contacted by
*Fields are mandatory.


1. Hindricks G, Taborsky M, Glikson M, et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. The Lancet. 2014; 384 (9943): 583–590